Romanian Registry of Hypertrophic Cardiomyopathy – overview of general characteristics and therapeutic choices at a national level
暂无分享,去创建一个
B. Popescu | A. Ionescu | A. Frigy | R. Sascău | I. Coman | R. Jurcuț | C. Ginghinǎ | M. Roșca | E. Apetrei | C. Căldăraru | S. Militaru | C. Arsenescu-georgescu | A. Ionac | A. Fruntelata | A. Avram | S. Crișan | M. Chivulescu | A. Mursă | Nicoleta Ferariu | Paula Ionilă | Silvia F Goanţă | R. Jurcut | Monica Chivulescu | C. Arsenescu-Georgescu
[1] L. Tavazzi,et al. The Cardiomyopathy Registry of the EURObservational Research Programme of the European Society of Cardiology: baseline data and contemporary management of adult patients with cardiomyopathies , 2018, European heart journal.
[2] J. Moon,et al. Update on hypertrophic cardiomyopathy and a guide to the guidelines , 2016, Nature Reviews Cardiology.
[3] L. Tavazzi,et al. European Cardiomyopathy Pilot Registry: EURObservational Research Programme of the European Society of Cardiology. , 2016, European heart journal.
[4] Martin Borggrefe,et al. [2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy]. , 2014, Kardiologia polska.
[5] F. Rutten,et al. 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). , 2014, European heart journal.
[6] P. Elliott,et al. Atrial fibrillation and thromboembolism in patients with hypertrophic cardiomyopathy: systematic review , 2013, Heart.
[7] M. Maron,et al. Controversies in cardiovascular medicine Pharmacological treatment options for hypertrophic cardiomyopathy : high time for evidence , 2012 .
[8] M. Desai,et al. Cardiac magnetic resonance in hypertrophic cardiomyopathy. , 2011, JACC. Cardiovascular imaging.
[9] M. Sheppard,et al. Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy using cardiovascular magnetic resonance , 2010 .
[10] M. Link,et al. Hypertrophic Cardiomyopathy Is Predominantly a Disease of Left Ventricular Outflow Tract Obstruction , 2006, Circulation.
[11] A. Gavazzi,et al. The Italian Registry for hypertrophic cardiomyopathy: a nationwide survey. , 2005, American heart journal.
[12] M. Link,et al. Gender-related differences in the clinical presentation and outcome of hypertrophic cardiomyopathy. , 2005, Journal of the American College of Cardiology.
[13] B. Maron,et al. Spectrum and prognostic significance of arrhythmias on ambulatory Holter electrocardiogram in hypertrophic cardiomyopathy. , 2005, Journal of the American College of Cardiology.
[14] P. Elliott,et al. Non-sustained ventricular tachycardia in hypertrophic cardiomyopathy: an independent marker of sudden death risk in young patients. , 2003, Journal of the American College of Cardiology.
[15] B. Maron. Hypertrophic cardiomyopathy: a systematic review. , 2002, JAMA.
[16] B. Maron,et al. Impact of Atrial Fibrillation on the Clinical Course of Hypertrophic Cardiomyopathy , 2001, Circulation.
[17] W. Weaver. Results of the RAPID 1 and RAPID 2 thrombolytic trials in acute myocardial infarction. , 1996, European heart journal.
[18] H. Mcintosh,et al. Ethics in cardiovascular medicine. Task Force II: The relation of cardiovascular specialists to patients, other physicians and physician-owned organizations. , 1990, Journal of the American College of Cardiology.
[19] D. Waters,et al. Long-term prognosis after myocardial infarction in patients with previous coronary artery bypass surgery. , 1988, Journal of the American College of Cardiology.
[20] K. Huynh. Hypertension: SPRINTing towards a new target for blood-pressure control , 2016, Nature Reviews Cardiology.